Über uns_schmied.edit

Franjo Grotenhermen completed his studies in medicine and received his doctorate (Dr. medical in Cologne. His fields of activity included internal medicine, surgery and naturopathic treatment. He runs a medical practice in Steinheim (Westphalia) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is Managing Director of the Working Group Cannabis as Medicine e.V. (ACM), Managing Director of the International Working Group for Cannabinoid Drugs (IACM) and author of the IACM information, which has been published fortnightly in several languages on the IACM website for more than 20 years. Grotenhermen is an employee of the Cologne nova Institute, co-owner of Endoxo GmbH (founded 2019) and Head of Scientific Committee of MYCB1 (since 2019). He received the following awards: Cannabusiness Hemp Prize 1999, IACM 2011 Special Award, ICBC 2018 Lifetime Achievement Award, Robert Newman Memorial Prize 2018 from Akzept e.V.

 

Stefan Nölker-Wunderwald, the founder of the Hanf-Zeit company, has been passionately committed to making the hemp plant socially acceptable again and promoting regional hemp cultivation for over 20 years. Nölker-Wunderwald has already won the Product Award 2000 (Anti-Stress & Hemp Scented Pillow) and together with Wulf Niehus won the Innovation Award for hemp products with "Spirit-of-Hemp-Roots" from the EIHA in 2018.

With Endoxo GmbH (2019) we have now succeeded in presenting a joint product line together with the expert in the field of cannabinoids (Dr. Grotenhermen). Going this way together with Endoxo in order to combine expertise with fair products spurs on Stefan Nölker-Wunderwald.